--- title: Preclinical In Vitro Studies CROs path: /services/preclinical-in-vitro companies_count: 61 --- # Preclinical In Vitro Studies CROs 61 published CROs match Preclinical In Vitro Studies. Locations in this set include United States, China, United Kingdom, India, Canada, and France. Capabilities that show up most often in this set: Small Molecule, Cell Therapy, Biologics (Other), Biologics (Monoclonal Antibodies), and Gene Therapy. ## Matching companies - [AMSbiopharma](/companies/amsbiopharma) - Analytical CRO providing comprehensive analytical services for drug research, preclinical development, and quality control across pharmaceutical and biopharmaceutical industries. - [Acres Biosciences](/companies/acresbiosciences) - San Diego CRO offering cell line engineering, high-throughput and functional assay development, and in vivo PK/PD and toxicity studies. Work spans oncology, fibrosis, and metabolic disease models, with T cell engager and ADC assay services. - [Allucent](/companies/allucent) - Allucent is a full-service CRO specializing in clinical development solutions for small and mid-sized biotech companies. - [Altasciences](/companies/altasciences) - Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities. - [Aragen Life Sciences](/companies/aragen) - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe. - [Avigen Ltd](/companies/avigen) - Avigen offers avidity-based profiling of live immune–target cell interactions for immunotherapy discovery and preclinical validation. Its platform supports TCR-T, CAR-T, and NK programmes across solid tumour indications. - [Axcelead Drug Discovery Partners, Inc.](/companies/axcelead) - Axcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities. - [Axxam](/companies/axxam) - Contract research organization specializing in integrated drug discovery services, from target validation to hit and lead identification across therapeutic areas. - [BioDuro-Sundia](/companies/bioduro-sundia) - BioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission. - [BioLegacy Research](/companies/biolegacy) - San Diego-based preclinical CRO specializing in GLP toxicology, in vivo pharmacology, custom animal models, and medical device testing across rodent to non-human primate species. - [Biotest Facility](/companies/bioxpedia) - Danish CRO offering in vivo models, proteomics, transcriptomics, biomarker discovery, and bioinformatics to support biotech and pharma research from concept to validated data. - [Cadena Research](/companies/cadena-research) - Cadena Research is a CRO specializing in preclinical development of radiopharmaceuticals, offering laboratory services, radiochemistry expertise, regulatory guidance, and scientific advisory support to accelerate drug development and approval. - [Cardiomedex](/companies/cardiomedex) - Cardiomedex is a preclinical CRO specialized in cardiovascular disease models, offering in vivo efficacy studies, ex vivo functional exploration, and in vitro assays for drug candidates targeting heart failure, myocardial infarction, hypertension, and cardiometabolic complications. - [Certara](/companies/certara) - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making. - [Certis Oncology Solutions, Inc.](/companies/certisoncology) - Certis Oncology Solutions provides translational oncology research services including custom cancer models, in vitro/ex vivo pharmacology, in vivo pharmacology, imaging analysis, and immuno-oncology studies for drug developers. - [Champions Oncology](/companies/championsoncology) - Leading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services. - [ChemDiv](/companies/chemdiv) - ChemDiv is a fully integrated target-to-clinic CRO headquartered in San Diego, CA, offering drug discovery services including medicinal chemistry, CADD, ADME/DMPK, toxicology, and custom synthesis alongside the industry's largest commercial screening library of 1.6M compounds. - [ChemPartner](/companies/chempartner) - Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide. - [Creative Bioarray](/companies/creative-bioarray) - Creative Bioarray provides preclinical research solutions including drug screening, ADME-PK, toxicity studies, and cell-based services across oncology, neurology, cardiovascular, and metabolic therapeutic areas. - [Creative Diagnostics](/companies/antiviral) - Creative Diagnostics provides antiviral and antibacterial assays, cell-based compound screening, and in vivo model solutions with BSL-2 and BSL-3 capabilities for drug and vaccine development.